Home/Filings/4/0001209191-17-014340
4//SEC Filing

MEDNAX, INC. 4

Accession 0001209191-17-014340

$MDCIK 0000893949operating

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:31 PM ET

Size

8.8 KB

Accession

0001209191-17-014340

Insider Transaction Report

Form 4
Period: 2017-02-23
SOSA ENRIQUE
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2017-02-23$32.33/sh+10,668$344,84321,923 total
  • Sale

    Common Stock

    2017-02-23$69.65/sh10,668$743,06011,255 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2017-02-23$32.33/sh10,668$344,8430 total
    Exercise: $32.33From: 2010-11-01Exp: 2017-11-01Common Stock (10,668 underlying)
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in twenty-six (26) separate transactions with prices ranging from $69.49 to $69.74 for an average weighted sales price of $69.6532. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

MEDNAX, INC.

CIK 0000893949

Entity typeoperating
IncorporatedFL

Related Parties

1
  • filerCIK 0000893949

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:31 PM ET
Size
8.8 KB